Your browser doesn't support javascript.
loading
Show Me CKDintercept Initiative: A Collective Impact Approach to Improve Population Health in Missouri.
Laue, Katelyn; Schultz, Megan; Talbot-Montgomery, Elizabeth; Garrick, Alexandra; Java, Anuja; Corbett, Christine; Lammert, Dana M; Rogers, JoAnna; Davis, Kathleen; Malhotra, Kunal; Philipneri, Marie; Kimbel, Mary Ann; Mustafa, Reem A; Hardesty, Valerie.
Affiliation
  • Laue K; National Kidney Foundation, New York, NY.
  • Schultz M; National Kidney Foundation, New York, NY.
  • Talbot-Montgomery E; National Kidney Foundation, New York, NY.
  • Garrick A; National Kidney Foundation, New York, NY.
  • Java A; Division of Nephrology, Washington University School of Medicine, St. Louis, MO.
  • Corbett C; University Health, Kansas City, MO.
  • Lammert DM; Health Quality Innovators, Richmond, VA.
  • Rogers J; National Kidney Foundation, NKF Serving Kansas and Western Missouri, Kansas City, MO.
  • Davis K; National Kidney Foundation, NKF Serving Eastern Missouri, Metro East, and Arkansas, St. Louis, MO.
  • Malhotra K; Division of Nephrology, University of Missouri, Columbia, MO.
  • Philipneri M; Saint Louis University School of Medicine, Internal Medicine/Nephrology, Saint Louis, MO.
  • Kimbel MA; Health Quality Innovators, Richmond, VA.
  • Mustafa RA; Division of Nephrology and Hypertension, University of Kansas Medical Center, Kansas City, KS.
  • Hardesty V; Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, Canada.
Mayo Clin Proc Innov Qual Outcomes ; 8(1): 82-96, 2024 Feb.
Article in En | MEDLINE | ID: mdl-38283097
ABSTRACT
Ninety percent of people with chronic kidney disease (CKD) remain undiagnosed, most people at risk do not receive guideline-concordant testing, and disparities of care and outcomes exist across all stages of the disease. To improve CKD diagnosis and management across primary care, the National Kidney Foundation launched a collective impact (CI) initiative known as Show Me CKDintercept. The initiative was implemented in Missouri, USA from January 2021 to June 2022, using a data strategy, stakeholder engagement and relationship mapping, learning in action working groups (LAWG), and a virtual leadership summit. The Reach, Effectiveness, Adoption, Implementation, and Maintenance framework was used to evaluate success. The initiative united 159 stakeholders from 81 organizations (Reach) to create an urgency for change and engage new CKD champions (Effectiveness). The adoption resulted in 53% of participants committed to advancing the roadmap (Adoption). Short-term results reported success in laying a foundation for CI across Missouri. The long-term success of the CI initiative in addressing the public health burden of kidney disease remains to be determined. The project reported the potential use of a CI initiative to build leadership consensus to drive measurable public health improvements nationwide.

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Guideline Language: En Journal: Mayo Clin Proc Innov Qual Outcomes Year: 2024 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Guideline Language: En Journal: Mayo Clin Proc Innov Qual Outcomes Year: 2024 Document type: Article